A/s Novo, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), bought 1,106,592 shares at $13.00 ($3.2M) on 2016-10-31, disclosed to the SEC on 2016-11-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 860,438 | $0 | 0.0% |
| 2 | $13.00 | 246,154 | $3.2M | 100.0% |
| Total | $2.89 avg | 1,106,592 | $3.2M | 100% |
| Filing → |
| RETA | SELL | 2017-06-12 | $5.7M | — | Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |